Thyroid Cancer: Overview
Thyroid cancer is one of the rare cancers in which is a tiny gland located near the base of the neck. It is a butterfly-shaped gland that develop in the front side of the neck. It is known for releasing thyroid hormone, a substance that regulates the body’s metabolism. Hormones produced by the thyroid regulate processes such as temperature regulation and metabolism. Thyroid cancer develops when abnormal cells in the thyroid gland reproduce and expand. Thyroid cancers are classified by the type of cell in which they develop.
Thyroid cancer affects more than 20,000 people in the United States each year, but it only accounts for 1% of all new cancer diagnoses. While the number of thyroid cancers identified has increased in the last 30 years, the death rate from thyroid cancer has stayed constant, according to research from the National Cancer Institute in the United States. The majority of solitary thyroid nodules (lumps) are benign, but if they occur in people under the age of 30 or over the age of 60, the risk of malignancy increases. Women are prone get affected by the thyroid cancer as compared to the men, and it occurs at a slightly younger age.
Report Key Takeaways
Recommended Treatment for Thyroid Cancer:
- Total thyroidectomy
- The purpose of this surgery for thyroid cancer is to totally remove the thyroid gland and hopefully ensure that cancer does not return.
- Lymph node resection
- Thyroid cancer can spread to nearby lymph nodes, which are frequently resected. Lymph nodes that have been affected may only be discovered during surgery.
- Lobectomy
- The isthmus is a fibrous tissue bridge that usually connects the thyroid with two lobes. The surgeon may only remove the damaged lobe if the tumour is limited to a tiny area.
- Open biopsy
- In this treatment, a surgeon performs surgery to completely remove the nodule. After its removal, all tissues are transferred to the pathologist for detection of malignancy.
Recent Developments Related to Thyroid Cancer
- According to research presented at the Multidisciplinary Head and Neck Cancers Symposium, a multimodal artificial intelligence (AI) platform may accurately identify thyroid cancer using standard ultrasound scans. Radiomics, deep learning, topological data analysis, and machine learning are among the AI methods used in the platform.
- Natco Pharma has announced the official launch of their first generic version of Nexavar tablets that will be available the US market. It’s a multikinase inhibitor that’s taken orally and used to treat advanced renal cell, liver, and thyroid cancers.
Major Players Working on Thyroid Cancer
AffyImmune Therapeutics, Inc., Bristol-Myers Squibb, Boston Pharmaceuticals, Hutchison Medipharma Limited, Debiopharm, Novartis Oncology, Iovance Biotherapeutics, Inc., Applied Pharmaceutical, Takeda Oncology, and Genentech, Inc. and. are some of the key players that working on the research and development activities related to thyroid cancer.
Key Reasons to Purchase This Report
- The pipeline insight provides detailed information on the pipeline outlook, medication profiles, and clinical and non-clinical stage candidates.
- A comprehensive analysis of the disease, including historical and projected epidemiology, market drivers, market trends, market barriers, and prominent thyroid cancer companies.
- A comparison of the pipeline landscapes of leading companies, encompassing details regarding the recent developments and the latest launched products.
